GSP Crop Science IPO Details
Issue Date
16 Mar - 18 Mar'26
Price Range
₹304 - ₹320
Lot Size
46
IPO Size
₹400 Cr
GSP Crop Science IPO Listing Details
Listing On
24 Mar'26
Issue Price
₹320
Listed Price
₹ 332.3
Retail Gain/Listing Gain
▲3.84%
Schedule of GSP Crop Science IPO
Start date
16/03/2026
End date
18/03/2026
Allotment of bids
20/03/2026
Refund Initiation
23/02/2026
Listing on exchange
24/03/2026
GSP Crop Science IPO Subscription Status Live
(Last updated on 18 Mar 2026 04:45 PM)
Day 1 16-Mar-2026 | 0.47x | 1.28x | 0.1x | 0.28x |
Day 2 17-Mar-2026 | 0.95x | 1.28x | 0.2x | 2.26x |
Day 3 18-Mar-2026 | 1.6x | 2.66x | 0.39x | 3.04x |
GSP Crop Science IPO Subscription Rate
Qualified Institutions | 2.66x |
Non-Institutional (HNI) | 3.05x |
Retail | 0.4x |
Total Subscription | 1.6x |
About GSP Crop Science IPO
The GSP Crop Science IPO opens on Monday, March 16, 2026 and closes on Wednesday, March 18, 2026. The allotment of shares will take place on Friday, March 20, 2026. The credit of shares to the demat account will take place on Monday, March 23, 2026. The initiation of refunds will take place on Monday, March 23, 2026. The listing of shares will take place on Tuesday, March 24, 2026.
The offer consists of both a fresh issue and an offer for sale component. The fresh issue will include 0.75 crore shares aggregating to ₹240.00 crores. The offer for sale portion includes 0.50 crore shares aggregating to ₹160.00 crores. The total number of shares and aggregate amount are 1,25,00,000 shares (aggregating up to ₹400 crores).
GSP Crop Science price band is set at ₹304 to ₹320 per share. The lot size for an application is 46. The minimum amount of investment required by a retail investor is ₹14,720 (46 shares) (based on upper price). The lot size investment required by sNIIs is 14 lots (644 shares), amounting to ₹2,06,080, and for bNII, it is 68 lots (3,128 shares), amounting to ₹10,00,960.
GSP Crop Science is a research-driven agrochemical company, specializing in the development and manufacturing of insecticides, herbicides, fungicides and plant growth regulators in India, with over 39 years of experience in the agrochemical industry. They provide their customers with crop protection solutions designed to support farmers in maximizing productivity and achieving optimal agricultural output through development, manufacturing, supply and distribution.
Objectives of GSP Crop Science IPO
The Net Proceeds of the Fresh Issue are proposed to be utilised in the following manner:
- Repayment or pre-repayment of all or a portion of certain outstanding borrowings availed by our Company.
- General corporate purposes.
GSP Crop Science IPO Valuation
Upper Price Band | ₹320 |
Fresh Issue | 75,00,000 shares (aggregating up to ₹240 crores) |
Offer for Sale | 50,00,000 shares of ₹10 (aggregating up to ₹160 crores) |
EPS Diluted (in ₹) for FY25 | 21.20 |
Share Offer and Subscription Details
QIBs | Not more than 50% of the Net Offer |
Non-institutional Investors (NIIs) | Not less than 15% of the Net Offer |
Retail-individual Investors (RIIs) | Not less than 35% of the Net Offer |
GSP Crop Science IPO Lot Size
Assets | 2,911.12 | 2,682.80 | 2,171.37 | 1,919.53 |
Total Income | 1,543.93 | 2,177.53 | 1,770.18 | 1,398.78 |
Profit After Tax | 425.36 | 666.91 | 503.23 | 296.66 |
Net Worth | 2,153.78 | 2,041.85 | 1,591.61 | 1,217.65 |
Industry Outlook
India’s agriculture market output plays a key role in the country's economy, providing food security while also contributing significantly to India’s GDP. Recent developments in agriculture practices, improved technology, rise in investments coupled with favourable government policies have led to robust growth in the sector. Crops like rice, wheat, sugarcane, and cotton dominate the agriculture landscape forming the cornerstone of India’s agriculture output.
Company Information
GSP Crop Science is a research-driven agrochemical company with 39+ years of experience. It specialises in developing and manufacturing insecticides, herbicides, fungicides, and plant growth regulators in India. Focused on crop protection solutions, it offers formulations (active ingredients with additives) and technicals (concentrated active ingredients for formulations). They have adopted a multi-faceted approach to their business, by establishing presence in both domestic and international markets. This strategy allows them to effectively cater to diverse customer needs and capitalize on opportunities across various regions.
As of September 30, 2025, they have five manufacturing facilities located at Odhav (Ahmedabad, Gujarat), Kathwada (Ahmedabad, Gujarat), Nandesari (Vadodara, Gujarat), Samba (UT of Jammu & Kashmir) and Saykha (Dahej, Gujarat). As of September 30, 2025, they have an annual aggregated installed capacity of 15,120 MTPA for technicals, 43,672 MTPA for formulations and 5,400 MTPA for intermediates across their five manufacturing facilities.
GSP Crop Science IPO Strengths
A well diversified portfolio of insecticides, herbicides, fungicides, and growth regulators positions them as a comprehensive solution provider.
A research-driven agrochemical company, it specialises in developing and manufacturing insecticides, herbicides, fungicides, and plant growth regulators in India. With strong product development capabilities, it operates across Formulations and Technicals. As of September 30, 2024, the company holds 507 registrations across both segments, driven by its focus on research and innovation.
Serving a diverse clientele domestically and internationally.
The company has established strong B2B relationships in both domestic and international markets, enabling the expansion of product offerings and geographic reach. Its ability to manufacture complex off-patent formulations and technicals cost-effectively while meeting strict quality and environmental standards has fostered long-standing customer associations, with several partnerships exceeding 10 years. Key clients include Bharat Rasayan, Dharmaj Crop Guard, Indogulf Cropsciences, SML, Willowood Chemicals, and Agrico Organics. A diverse customer base minimises reliance on any single client, enhancing resilience and adaptability in dynamic market conditions.
Strong in-house R&D capabilities with a focus on innovation and product development.
The company’s R&D-driven approach has enabled the development of advanced technological processes for its facilities and a proven track record in introducing Formulations and Technicals to the Indian agrochemical market (Source: ICRA Report). In 2022, it commissioned an R&D and pilot plant facility to test product commercialisation, focusing on new off-patent products, process improvements, and quality enhancement. Investments in R&D facilities include a Formulation facility in Kathwada and a technical facility in Odhav, both equipped for complex chemistries. The company specialises in manufacturing Chlorantraniliprole Technical (96% purity), Clothianidin Technical (98% purity), and Pymetrozine Technical (98% purity).
Risks of GSP Crop Science IPO
-
Require certain approvals and licenses, including certain registrations from the Central Insecticides Board and Registration Committee for their products.
-
Subject to stringent technical specifications and quality requirements in relation to their technicals and formulations.
-
Required to comply with the applicable regulations of the international geographies and obtain registrations from foreign governmental authorities.
-
Depend on a few suppliers for supply of raw materials.
-
Do not enter into long-term agreements with their customers.
-
Dependent on their distribution network for the distribution of formulations in their B-to-C domestic business.
-
Business is sensitive to seasonal vagaries and adverse weather conditions which affect the agrochemical industry.
-
Any adverse impact on the global or domestic agrochemical industry could have an adverse impact on the business.
All Financial Information about GSP Crop Science IPO
Comparison with peers
GSP Crop Science | 1287.385 | NA | 21.20 | 115.34 |
Peers | ||||
PI Industries Limited | 7977.800 | 28.25 | 109.42 | 669.47 |
Sumitomo Chemical India Limited | 3148.524 | 39.23 | 10.13 | 58.12 |
Dhanuka Agritech Limited | 2035.152 | 15.13 | 65.55 | 311.17 |
Source: The financial information for GSP Crop Science is based on the Restated Consolidated Financial Information for Fiscal 2025. The financial information for listed industry peers mentioned above is on a consolidated basis, if applicable and is sourced from the financial statements of the respective company for Fiscal 2025 submitted to the Stock Exchanges. The listed industry peers mentioned above have been identified considering Indian listed peers who operate in the agrochemical industry and based on the following parameters: (i) size, and (ii) product range. Notes: (1) Basic EPS and Diluted EPS refer to the Basic EPS and Diluted EPS sourced from the financial statements of the respective company (2) P/E Ratio has been computed based on the closing market price of equity shares for Fiscal 2025 on BSE on March 5, 2026 divided by the Diluted EPS for Fiscal 2025. (3) Return on net worth (RoNW) is computed as Profit/(Loss) for the year (Excluding share of minority in profits) divided by Total equity (Excluding non-controlling interest) (4) Return on net worth (RoNW) for GSP Crop Science is calculated as restated profit for the period/year from continuing operations attributable to equity shareholders of the parent divided by Net Worth. Net Worth is calculated as Total Equity less non-controlling interest and capital reserve. (5) NAV per equity share has been computed as the Equity attributable to common shareholders (excluding non-controlling interest) divided by the total number of shares outstanding, for Fiscal 2025. The NAV for GSP Crop Science has been adjusted for sub-division of face value from ₹ 100 to ₹ 10 per equity share and the bonus issuances made by GSP Crop Science. (6) NAV per equity share for GSP Crop Science is calculated as Net Worth divided by number of equity shares outstanding at the end of the period/year. Net Worth is calculated as Total Equity less non-controlling interest and capital reserve.
Anchor Investor Bidding Date: Friday, March 13, 2026
Registrar: MUFG Intime India Private Limited (Formerly Link Intime India Private Limited)
Book Running Lead Managers:
Equirus Capital Private Limited
Motilal Oswal Investment Advisors Limited
GSP Crop Science Business Model
The company earns its revenue by specialising in the development and manufacturing of insecticides, herbicides, fungicides, and plant growth regulators in India. It provides crop protection solutions through formulations (active ingredients with additives) and technicals (concentrated active ingredients for formulations).
GSP Crop Science Growth Trajectory
The company’s Total Income was ₹1301.056 crores in FY2025, ₹1158.228 crores in FY2024, and ₹1206.047 crores in FY2023.
Their Profit After Tax was ₹81.420 crores in FY2025, ₹55.540 crores in FY2024, and ₹17.573 crores in FY2023.
EBITDA was ₹164.033 crores in FY2025, ₹130.405 crores in FY2024, and ₹81.282 crores in FY2023.
GSP Crop Science Market Position
As of September 30, 2025, they have received 524 registrations across formulations and technicals for agrochemicals manufactured by them.
In their international business, they catered to 253 customers in 37 countries during the six months ended September 30, 2025, Fiscals 2025, 2024 and 2023, including in Latin America, Asia Pacific (excluding India), North America and other geographies. The countries primarily included Uruguay, United States of America, Vietnam, Brazil, Singapore, Bangladesh, United Arab Emirates, Taiwan, Australia and Sri Lanka.
As of 31 March 2025, the company’s Total Income, Profit After Tax, and EBITDA were ₹1301.056 crores, ₹81.420 crores, and ₹164.033 crores, respectively.
GSP Crop Science Profit and Loss Statement (in ₹ crores)
Total Income | 1301.056 | 1158.228 | 1206.047 |
Profit Before Tax | 109.681 | 76.556 | 23.323 |
Profit After Tax | 81.420 | 55.540 | 17.573 |
EPS (Diluted) ₹ | 21.20 | 13.49 | 4.20 |
EBITDA | 164.033 | 130.405 | 81.282 |
GSP Crop Science Balance Sheet (in ₹ crores)
Profit Before Tax | 109.681 | 76.556 | 23.323 |
Net Cash from Operating Activities | 37.832 | 206.742 | 103.515 |
Net Cash from Investing Activities | (79.880) | (18.961) | (46.812) |
Net Cash from Financing Activities | 29.846 | (178.327) | (158.944) |
Cash & Cash Equivalents | 18.075 | 29.964 | 20.457 |
Note: () denotes negative
How to Apply for GSP Crop Science IPO?
Here are the steps to apply for GSP Crop Science Ltd IPO:
-
Step 1: Log in to your Kotak Neo Demat account - Log in to your Demat account to access IPO investments. Next, select the current IPO section.
-
Step 2: Specify IPO details - Enter the number of lots and the price you wish to apply for.
-
Step 3: Enter UPI ID - After entering your UPI ID, click submit. This will place your bid with the exchange.
-
Step 4: Mandate Notification - Your UPI app will receive a mandate notification to block funds.
-
Step 5: Approve Request - Your funds will be blocked once you approve the mandate request on your UPI.
GSP Crop Science IPO FAQs
The GSP Crop Science IPO opens for subscription from 16-03-2026 to 18-03-2026, with a total issue size of ₹400 Cr. The IPO price band is ₹304 to ₹320 per share with a lot size of 46. The company aims to list the shares on BSE & NSE on 24-03-2026.
The GSP Crop Science IPO will open for subscription on 16-03-2026 and will close on 18-03-2026 for investors.
The minimum lot size for the GSP Crop Science IPO is 46 equity shares, requiring a minimum investment of ₹14720 for retail investors applying in the IPO.
The price band of the GSP Crop Science IPO has been fixed at ₹304 to ₹320 per equity share.
You can apply for the GSP Crop Science IPO online through the Kotak Neo Website or the Kotak Neo App using UPI or ASBA during the IPO subscription period.
GSP Crop Science IPO allotment will take place on 20-03-2026.
You can check the GSP Crop Science IPO allotment status online on the registrar’s website or on the NSE and BSE IPO allotment pages using your application number, PAN, or demat account details.
GSP Crop Science shares will list on the stock exchanges on 24-03-2026.
You can find detailed information about the GSP Crop Science IPO, including its business operations, financial performance, risk factors, and IPO objectives, in the Draft or Red Herring Prospectus (RHP).
The GSP Crop Science Ltd IPO is a 100% book-built issue comprising a fresh offer and an offer-for-sale. The fresh issue size is pegged at ₹280 crores.
Yes, GSP Crop Science Ltd is expected to come up with its IPO soon.
Bhavesh Vrajmohan Shah is the CEO of GSP Crop Science Ltd.
You can read more about GSP Crop Science IPO and its business from the company’s red herring prospectus here: < GSP Crop Science RHP>
Bhavesh Vrajmohan Shah is the Chairman and Managing Director of GSP Crop Science.
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Neo Research Team, nor is it a report published by the Kotak Neo Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
Trending IPOs
27 Mar - 08 Apr'26 | |||||||||
10 Apr - 16 Apr'26 | |||||||||
06 Apr - 08 Apr'26 | |||||||||
To be announced | |||||||||
To be announced | |||||||||
Trending IPOs
27 Mar - 08 Apr'26 | |||||||||
10 Apr - 16 Apr'26 | |||||||||
06 Apr - 08 Apr'26 | |||||||||
To be announced | |||||||||
To be announced | |||||||||